James Warren Huff

Insider Reports History

Location
Irving, TX
Signature
/s/ Tracy Herson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Warren Huff:

Company Role Class Num Shares Value Price $ Report Date Ownership
REATA PHARMACEUTICALS INC Chief Executive Officer, Director Class A common stock 0 $172.03 26 Sep 2023 By The 2021 JWH GRAT
REATA PHARMACEUTICALS INC Chief Executive Officer, Director Class A common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Chief Executive Officer, Director Class B common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Chief Executive Officer, Director Employee Stock Option (right to buy) 0 26 Sep 2023 Direct

Insider Reports Filed by James Warren Huff

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323019535-huff-james-warren-2023-09-26 REATA PHARMACEUTICALS INC 26 Sep 2023 13 $0 4 Chief Executive Officer, Director 26 Sep 2023, 16:30
/report/000120919123041925-huff-james-warren-2023-07-06 REATA PHARMACEUTICALS INC 06 Jul 2023 3 $0 4 Chief Executive Officer, Director 10 Jul 2023, 16:38
/report/000120919123015713-huff-james-warren-2023-03-01 REATA PHARMACEUTICALS INC 01 Mar 2023 13 -$6,409,473 4 Chief Executive Officer, Director 03 Mar 2023, 16:09
/report/000120919123001220-huff-james-warren-2023-01-03 REATA PHARMACEUTICALS INC 03 Jan 2023 2 $0 4 Chief Executive Officer, Director 04 Jan 2023, 16:35